eHealth, Inc. (NASDAQ:EHTH) reached 318.63% versus a 1-year low price of $14.17. The stock was last seen 4.94% higher, reaching at $59.32 on 3/15/2019. At a recent session, the prices were hovering between $56.68 and $60.61. This company shares are 21.61% off its target price of $72.14 and the current market capitalization stands at $1.14B. The recent change has given its price a 10.01% lead over SMA 50 and -12.04% deficit over its 52-week high. The stock witnessed -2.31% declines, 61.63% gains and 118.89% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found EHTH’s volatility during a week at 6.48% and during a month it has been found around 6.37%.

eHealth, Inc. (EHTH) Top Holders

Institutional investors currently hold around $1.1 billion or 96.8% in EHTH stock. Look at its top three institutional owners: Blackrock Inc. owns $152.19 million in eHealth, Inc., which represents roughly 13.35% of the company’s market cap and approximately 13.87% of the institutional ownership. Similar statistics are true for the second largest owner, Orbimed Advisors Llc, which owns 1,100,000 shares of the stock are valued at $65.25 million. The third largest holder is Redmile Group, Llc, which currently holds $64.74 million worth of this stock and that ownership represents nearly 5.68% of its market capitalization.

eHealth, Inc. 13F Filings

At the end of December reporting period, 88 institutional holders increased their position in eHealth, Inc. (NASDAQ:EHTH) by some 3,552,629 shares, 49 decreased positions by 3,412,437 and 18 held positions by 11,533,754. That puts total institutional holdings at 18,498,820 shares, according to SEC filings. The stock grabbed 37 new institutional investments totaling 1,786,474 shares while 11 institutional investors sold out their entire positions totaling 442,867 shares.

eHealth, Inc. (EHTH) Analyst Guide

Several analysts have released their opinion on eHealth, Inc. (NASDAQ:EHTH), with 0 analysts believing it is a strong buy. Whereas 2 of them predict the stock is a hold. Also, there are 6 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.25 average brokerage recommendation [T1].